News

Pfizer Inc. and Biohaven Pharmaceutical Holding Company Ltd. announced that the European Commission (EC) has granted marketing authorization for VYDURA (rimegepant), a calcitonin…
Read More...

Daiichi Sankyo and AstraZeneca’s ENHERTU (fam-trastuzumab deruxtecan-nxki) has been granted Breakthrough Therapy Designation (BTD) in the U.S. for the treatment of adult patients with…
Read More...

RVAC Medicines Pte. Ltd. an emerging messenger RNA (mRNA) platform company incubated in Singapore by CBC Group ("CBC"), announced the completion of its series B financing, bringing the…
Read More...

Castle Biosciences, Inc. announced that it has completed its acquisition of AltheaDx, Inc. (AltheaDx). AltheaDx is a commercial-stage molecular diagnostics company specializing in the…
Read More...

Virpax Pharmaceuticals, Inc. a company specializing in developing non-addictive product candidates for pain management, CNS disorders and anti-viral indications, reported preclinical…
Read More...

Isleworth Healthcare Acquisition Corp. a special purpose acquisition company and Cytovia Holdings, Inc.("Cytovia"), a biopharmaceutical company empowering natural killer (NK) cells to…
Read More...

STRIDE regimen of a single priming dose of tremelimumab added to Imfinzi is the first dual immune checkpoint blockade regimen to improve overall survival in a Phase III trial in…
Read More...

Turnstone Biologics Corp., a clinical-stage biotechnology company developing next-generation tumor-infiltrating lymphocyte (“TIL”) therapy and viral immunotherapy designed to treat and…
Read More...

Gilead Sciences, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Veklury (remdesivir) for the treatment of…
Read More...

Valneva SE a specialty vaccine company, today provided an update on the rolling review process of its inactivated, COVID-19 vaccine candidate, VLA2001, with the Committee for Medicinal…
Read More...

The University of Tokyo and Astellas Pharma Inc. entered the second phase of their collaboration for co-creating innovative new medicines and medical solutions, called the Astellas…
Read More...

Roche announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Tecentriq (atezolizumab) as an adjuvant…
Read More...

Breckenridge Pharmaceutical, Inc. announces today that it has signed a new-product agreement with PTS Pharma, LLC. under which PTS will support a technology transfer to Towa…
Read More...

Suzhou Porton Advanced Solutions Ltd. ('Porton Advanced') and Guizhou Sinorda Biomedicine Co. Ltd ('Sinorda Biomedicine') announced a long-term strategic partnership in cell and gene…
Read More...

Thermo Fisher Scientific today celebrated the opening of its new single-use technology manufacturing site in Ogden, Utah. The state-of-the-art facility creates additional capacity to…
Read More...

Enzyvant, a commercial-stage biotechnology company with a focus on regenerative medicines for rare diseases, announced today plans to develop a Good Manufacturing Practice…
Read More...

Dragonfly Therapeutics, Inc. ("Dragonfly"), a biotechnology company developing novel immunotherapies that harness the innate immune system to treat disease, announced an expansion of…
Read More...

Codexis, Inc. and seqWell, Inc. announced the initiation of a strategic partnership and investment to accelerate the commercialization of seqWell’s genomics workflow solutions. Codexis,…
Read More...

Samsung Biologics announced that it has completed the purchase of Biogen’s stake in the Samsung Bioepis joint venture for USD $2.3 billion. With the completion of the first payment of…
Read More...

BioArctic AB (publ) has announced that the company's partner AbbVie has decided to terminate its collaboration with BioArctic regarding the portfolio of alpha-synuclein antibodies,…
Read More...